pyrroles has been researched along with Bronchopulmonary Dysplasia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ishida, H; Ishii, R; Katsuragi, S; Kogaki, S; Narita, J; Ozono, K; Suginobe, H; Tsuru, H; Ueyama, A; Wang, R; Yoshihara, C | 1 |
Abman, SH; Kinsella, JP; Lin, YJ; Markham, NE; Maxey, A; McMurtry, IF; Tang, JR | 1 |
Abman, SH | 1 |
1 review(s) available for pyrroles and Bronchopulmonary Dysplasia
Article | Year |
---|---|
Bronchopulmonary dysplasia: "a vascular hypothesis".
Topics: Angiogenesis Inhibitors; Bronchopulmonary Dysplasia; Endothelial Growth Factors; Gene Expression Regulation, Developmental; Humans; Indoles; Infant, Newborn; Lymphokines; Proto-Oncogene Proteins; Pyrroles; Receptor Protein-Tyrosine Kinases; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Risk Factors; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors | 2001 |
2 other study(ies) available for pyrroles and Bronchopulmonary Dysplasia
Article | Year |
---|---|
Riociguat can ameliorate bronchopulmonary dysplasia in the SU5416 induced rat experimental model.
Topics: Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Disease Models, Animal; Humans; Hyperoxia; Indoles; Infant, Newborn; Lung; Models, Theoretical; Pyrazoles; Pyrimidines; Pyrroles; Rats | 2021 |
Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor.
Topics: Administration, Inhalation; Animals; Animals, Newborn; Bronchopulmonary Dysplasia; Enzyme Inhibitors; Female; Humans; Hypertension, Pulmonary; Indoles; Infant, Newborn; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pregnancy; Pulmonary Alveoli; Pyrroles; Rats; Receptors, Vascular Endothelial Growth Factor | 2004 |